CASE STUDY| I thought it was safe
A middle-aged woman taking the breast cancer drug Tamoxifen for ten years became concerned when she saw a news report with disturbing information. In some women, the drug made their cancer more aggressive and more likely to spread. Other women with breast cancer, the report stated, do not respond to Tamoxifen at all, and 30 to 40 percent of women who take the drug eventually become resistant to chemotherapy. The woman contacted her oncologist to ask some questions:
How can some people react one way to a cancer treatment and others react a different way?
Case summary:
A middle-aged woman was taking Tamoxifen drug as breast cancer treatment for 10 years. One day she came across a disturbing news, which said that different response was seen in different patients as this drug made cancer more aggressive and metastasize in the rest of the body in some patients. While other woman did not respond to the drug and 30–40% of women gradually became resistant to chemotherapy. The woman had some queries to be asked by her oncologist.
Characters in the case:
A middle-aged woman suffering from breast cancer for 10 years.
Adequate information:
The news report points out the different response of the patients to breast cancer treatment, in which some patient’s cancer has aggravated, few others do not show any response to the treatment, and around 40% have become resistant to chemotherapy.
To determine:
The reason for the different responses by different individuals for the drug to cancer treatment.
Explanation of Solution
Given information:
The drug for cancer shows variation in response in different group of individuals.
All the drugs designed for cancer treatment are DNA (deoxyribonucleic acid) damaging. The uncontrolled proliferation of cell is due to mutated DNA, which has to be destructed in order to inhibit tumor growth.
Pharmacogenomics is the field that studies the interaction of medicine with inherited genes. Although the same chemical agent is used as a drug for cancer therapy in all patients, even then different patients react differently to it, the following could be the reasons:
1. The different individual possesses different gene composition: The basic genome structure of all the individuals are same but the great diversity between the individuals of the same species is introduced due to 0.1% difference in genetic makeup. Thus, different cell lines react differently to the same drug.
2. The difference in the rate of metabolism: Different individuals have a different rate of metabolism. Few individuals may break down the drug fast as compared to another individual, making the treatment successful. Another individual may gradually metabolize the drug and the drug may persist for a long time in their body, this would not only cause adverse side effects but also may not give any response to the treatment.
3. The difference in drug activation and deactivation: On receiving a particular drug, certain enzymes are synthesized in the body, which helps in the activation of this drug but the drug activation does not occur in all the individuals. Similarly, drugs also need to undergo deactivation to inhibit the exposure to the healthy cells and limit the side effect of the drug.
4. The difference in DNA repair pathway: Once the DNA-damaging drugs are introduced, the cells will defend itself against the damage of DNA caused by chemotherapeutic drugs. The defense mechanism of cells includes DNA repair and other pathways but due to the difference in genetic makeup, every individual will have a slight variation among the genes involved in these pathways.
Therefore, it can be concluded that the basic composition of the genome is same in each and every individual but the great diversity, which is seen among individuals of same species, occurs due to a slight difference in the genetic makeup. The difference in response to cancer treatment is due to this difference in cell line or genes.
Want to see more full solutions like this?
Chapter 16 Solutions
Modified Mastering Genetics with Pearson eText -- Standalone Access Card -- for Essentials of Genetics (9th Edition)
- Lung cancer mitotic index: 0.25 Breast cancer mitotic index: 0.35 Skin cancer mitotic index: 0.4 Looking at the mitotic index for all 3 cancer types, which one is likely to be the most resistant (least affected) to the growth-inhibiting effects of traditional chemotherapy drugs that target rapidly dividing cells?arrow_forward1. "What genetic material was used in this research?" 2. How does the completion of this research advance the treatment of cancer? in typed pleasearrow_forwardGenetic instability in the form of point mutations, chromosome rearrangements, and epigenetic changes needs to be maximal to allow the development of cancer. (a) With diagrams explain point mutationsarrow_forward
- Why is it important to model cancer through the generation of induced pluripotent stem cells ? Please list item by item. Explain in detail the main findings.arrow_forwardHow to detect cancer? What are a few approaches to treat cancer?arrow_forwardCASE STUDY Cancer-killing bacteria Ralph, a 57-year-old man, was diagnosed with colon cancer.His oncologist discussed the use of radiation andchemotherapy as treatments, both of which can causedebilitating side effects. Ralph decided to explore other optionsand went to a cancer clinic. He learned that researchers in asynthetic biology program were testing the use of geneticallymodified bacterial cells designed to selectively invade specifictumors and kill cancer cells, with no effects on normal cells.Ralph decided to participate and was informed that he wouldbe part of a phase III trial, comparing the effects of the modifiedbacterial cell treatment against conventional chemotherapy.However, as part of the trial, he would be randomly assigned toreceive one or the other treatment. He was disappointed to learnthis, because he assumed that he would receive the bacterialtherapy.Question: Informed consent is legally and ethically required beforesomeone participates in a clinical trial.…arrow_forward
- 1. Brief introduction which introduces ALP as a diagnostic tool in cancer and create Graphical Abstract to summarise the role of ALP in cancer?arrow_forwardDescribe two mechanisms by which genetic change causes cancer.arrow_forwardWhen an invasive cancer occurs? A. When genetic mutation occurs in a cell B. Cells are abnormal and tumor are still in contained within its tissue of origin C. When cell's descendants mutated and divide excessively and look abnormal. D. When some cells have additional mutations and allow tumors to invade other tissues through circulatory system As a doctor, you observed that patient X has speech delay and taller than the normal person. You suspected that patient X has Klinefelter syndrome. What test should be done? A. Karyotype, to see whether he has 3 chromosomes in chromosome 21 that causes the order B. Karyotype, to see whether he has 3 chromosomes in chromosome 18 21 that causes the order. C. Fertility, because person with Klinefelter syndrome is sterile due to testicular atrophy and gynecomastia D. Fertility, because person with Klinefelter syndrome is infertile due to underdeveloped sexual characteristics Ben was asked by his teacher what happens if there is an uncontrolled…arrow_forward
- Biology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxBiology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage Learning
- Biology (MindTap Course List)BiologyISBN:9781337392938Author:Eldra Solomon, Charles Martin, Diana W. Martin, Linda R. BergPublisher:Cengage LearningHuman Biology (MindTap Course List)BiologyISBN:9781305112100Author:Cecie Starr, Beverly McMillanPublisher:Cengage Learning